Arterial Hypertension and Covid-19

Abstract

Taking into account the number of victims of a new coronavirus infection caused by the SARS-CoV-2 virus (COVID-19), on March 11, 2020, the World Health Organization declared a pandemic. Since December 2019, when the first case of SARS was detected in China, the first data have appeared on the characteristics of the course of infection in patients with various diseases. In particular, there have been reports of a greater susceptibility to infection in individuals with cardiovascular disease and, in particular, arterial hypertension, and a significantly higher risk of adverse outcomes in this group of patients. We present an analysis of the currently available publications regarding coronavirus infection in people with arterial hypertension. The article touches upon the issues of risks in patients with arterial hypertension against the background of coronavirus infection, including those associated with antihypertensive therapy (including blockers of the renin-angiotensin-aldosterone system), and approaches to the management of such patients.